• 2180 Citations
  • 24 h-Index
20032019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where youngae kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Tuberculosis Medicine & Life Sciences
Korea Medicine & Life Sciences
Latent Tuberculosis Medicine & Life Sciences
Lung Medicine & Life Sciences
Tuberculin Test Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Pneumonia Medicine & Life Sciences
Skin Tests Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 2180 Citations
  • 24 h-Index
  • 127 Article
  • 4 Review article
  • 2 Comment/debate
  • 1 Editorial
1 Citation (Scopus)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): Study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Lee, M., Mok, J., Kim, D. K., Shim, T. S., Koh, W. J., Jeon, D., Lee, T., Lee, S. H., Kim, J. S., Park, J. S., Lee, J. Y., Kim, S. Y., Lee, J. H., Jo, K. W., Jhun, B. W., Kang, Y. A., Ahn, J. H., Kim, C. K., Shin, S., Song, T. & 8 others, Shin, S. J., Kim, Y. R., Ahn, H., Hahn, S., Won, H. J., Jang, J. Y., Cho, S. N. & Yim, J. J., 2019 Jan 16, In : Trials. 20, 1, 57.

Research output: Contribution to journalArticle

Open Access
Linezolid
Pyrazinamide
Multidrug-Resistant Tuberculosis
Levofloxacin
Fluoroquinolones

Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis

Han, S. S., Lee, S. J., Yim, J. J., Song, J. H., Lee, E. H. & Kang, Y. A., 2019 Jan 1, In : PloS one. 14, 9, e0222810.

Research output: Contribution to journalArticle

Open Access
Latent Tuberculosis
health care workers
Rifampin
Korea
tuberculosis
1 Citation (Scopus)

Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes

Lee, E. H., Yong, S. H., Leem, A. Y., Lee, S. H., Kim, S. Y., Chung, K. S., Jung, J. Y., Park, M. S., Kim, Y. S., Chang, J. & Kang, Y. A., 2019 Apr 1, In : Open Forum Infectious Diseases. 6, 4

Research output: Contribution to journalArticle

Open Access
Extensively Drug-Resistant Tuberculosis
Multidrug-Resistant Tuberculosis
Fluoroquinolones
Linezolid
bedaquiline

In vitro mycobacterial growth inhibition in South Korean adults with latent TB infection

Lee, H., Kim, J., Kang, Y. A., Kim, D. R., Sim, B., Zelmer, A., Fletcher, H. A., Dockrell, H. M., Smith, S. G. & Cho, S. N., 2019 Jan 1, In : Frontiers in Immunology. 10, APR, 896.

Research output: Contribution to journalArticle

Open Access
Growth
Infection
Bacillus
Mycobacterium Infections
Staining and Labeling
1 Citation (Scopus)

Mortality of patients with chronic obstructive pulmonary disease: A nationwide population-based cohort study

Park, S. C., Kim, D. W., Park, E. C., Shin, C. S., Rhee, C. K., Kang, Y. A. & Kim, Y. S., 2019 Nov, In : Korean Journal of Internal Medicine. 34, 6, p. 1272-1278 7 p.

Research output: Contribution to journalArticle

Open Access
Chronic Obstructive Pulmonary Disease
Cohort Studies
Mortality
Population
National Health Programs